As the new year beckons, the pharmaceutical industry is poised for more developments, building on advances made in 2023. The industry harbors several companies leading the way in groundbreaking innovations, drug discoveries, pending approvals, and market advancements, an element likely to affect their stock price positively. Indeed, some key players will likely stand out in 2024 as they are backed by critical fundamentals that are likely to drive their stocks to higher valuations. In this regard, Finbold ha ...